Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2014 04/21/2014 04/22/2014 04/23/2014 04/24/2014 Date
149.8(c) 152.19(c) 156.1(c) 152.23(c) 156.01(c) Last
2 298 989 1 062 535 1 415 176 1 353 899 3 373 819 Volume
+0.50% +1.60% +2.57% -2.48% +2.48% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders. It focuses on developing products for the treatment of diseases in the... 
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 171 M
EBIT 2014 994 M
Net income 2014 736 M
Finance 2014 785 M
Yield 2014 -
Sales 2015 2 619 M
EBIT 2015 1 254 M
Net income 2015 903 M
Finance 2015 1 403 M
Yield 2015 -
PER 2014 45,01
PER 2015 35,31
EV / Sales 2014 13,9x
EV / Sales 2015 11,3x
Capitalization 30 881 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
1d ago ALEXION PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
1d ago ALEXION PHARMACEUTICALS : Reports First Quarter 2014 Results
1d ago ALEXION PHARMACEUTICALS : Initiates Multinational Registration Trials of Eculizu..
2d ago ALEXION PHARMACEUTICALS : Researchers to Present New Data on Asfotase Alfa in In..
2d ago ALEXION PHARMACEUTICALS : Announces the Appointment of John T. Mollen to Its Boa..
2d ago ALEXION PHARMACEUTICALS : European Commission Grants Orphan Drug Designation to ..
2d ago ALEXION PHARMACEUTICALS : Reports the Appointment of John T. Mollen to Its Board..
2d ago ALEXION PHARMACEUTICALS : Names John Mollen to Its Board
4d ago EMC : Alexion Announces the Appointment of John T. Mollen to Its Board of Direct..
04/17 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers, Amendments ..
04/17 ALEXION PHARMACEUTICALS : Announces the Appointment of John T. Mollen to Its Boa..
04/17ALEXION PHARMACEUTICALS, INC. : quaterly earnings release
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
Alexion Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Alexion Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF